Dr. Matthew Jiro Akiyama, MD
- Medicare services, 2022
- 114
- Part D claims, 2024
- 1,324
- Publications
- 98
- Clinical trials
- 1
- MIPS score, 2024
- 100
- Practice address
- 1621 Eastchester Rd, Bronx, NY 10461
- Practice phone
- Call (914) 377-4722
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Montefiore Medical Center
Bronx, New York
Find Dr. Akiyama's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Matthew Jiro Akiyama is an infectious disease specialist in Bronx, New York
Dr. Akiyama practices at Montefiore Medical Center in Bronx, New York.
Dr. Akiyama's NPI, 1316259419, was assigned on July 6, 2010. Dr. Akiyama holds New York license 279474.
- NPI
- 1316259419NPI Registry (opens in a new tab)
- Medicare PAC ID
- 1355659855
- NPI enumeration date
- July 6, 2010
- NPI status
- Active
- Practice phone
- (914) 377-4722
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 47
- Medical school graduation
- 2005
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. Matthew Jiro Akiyama practices at Montefiore Medical Center in Bronx, New York
Dr. Akiyama's primary practice is Montefiore Medical Center, at 1621 Eastchester Rd, Bronx, NY 10461 in Bronx County. The practice phone is (914) 377-4722.
- Montefiore Medical Center1621 Eastchester Rd, Bronx, NY 10461 · Bronx CountyPhone(914) 377-4722
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Matthew Jiro Akiyama is affiliated with 2 sites of care and 1 medical group
Dr. Akiyama's primary practice is Montefiore Medical Center in Bronx, New York. Dr. Akiyama is also affiliated with Montefiore Einstein Hospital-Moses Campus. The medical group on file is Montefiore Einstein Faculty Practice Group.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Matthew Jiro Akiyama's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Akiyama practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Montefiore Medical Center | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Matthew Jiro Akiyama is one of 825 infectious disease specialists in New York
Infectious disease is Dr. Akiyama's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Akiyama is licensed in New York.
Specialties and state licenses
- Infectious disease, New YorkPrimary
Infectious disease specialists near Dr. Akiyama
Counts of infectious disease specialists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Matthew Jiro Akiyama billed Medicare for 114 services in 2022
CMS data shows 114 Medicare services from Dr. Akiyama across 5 procedure codes in 2022. Medicare paid $11,003 for them.
Dr. Akiyama's Medicare services by type, 2021 to 2022
- 2021
- 2022
- Office and hospital visits
- 2021: 472022: 114143%
Where Dr. Akiyama's Medicare services took place, 2022
- In an office4640%
- In a facility6860%
Dr. Akiyama compared with the New York median for infectious disease specialists, 2022
- Dr. Akiyama
- New York median
- Medicare services
- 114vs 23852% below
- Part D claims
- 1,025vs 1626.3 times
Medians across 791 infectious disease specialists in New York with Dmand AI profiles that report each measure.
Dr. Akiyama's most billed Medicare procedure codes, 2022
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Akiyama?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Akiyama and other infectious disease specialists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Matthew Jiro Akiyama's patients have a median age of 64
Across all payers, Dmand AI patient panel data puts Dr. Akiyama's median patient age at 64, with 43% women.
Dr. Akiyama's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 64
Patient panel by sex, all payers
- Women43%
- Men57%
Source: Dmand AI Patient Panel Data
Dr. Matthew Jiro Akiyama wrote 1,324 Medicare Part D claims in 2024
In 2024, Dr. Akiyama wrote 1,324 Medicare Part D claims for 47 patients. 52% of them were for generic drugs. CMS names the drug for 1,025 of them, across 45 drugs with 11 or more claims each, at $1,189,897 in total drug cost. In 2023, CMS named 922 claims across 40 drugs.
Dr. Akiyama's Part D claims by kind of drug, 2024
- Generic694 claims52%
- Brand-name581 claims44%
- Other49 claims4%
Dr. Akiyama's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Akiyama's Part D claims, 2024
- Antibiotics1%18 of 1,324 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 9222024: 1,02511%
Drugs named by CMS: 45 in 2024, 40 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Matthew Jiro Akiyama scored 100 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Akiyama for performance year 2024, reported as part of a group.
Dr. Akiyama's MIPS scores, performance year 2024
- 100of 100Final score
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Matthew Jiro Akiyama has 98 publications on record
Dmand AI links 98 papers to Dr. Akiyama, published from 2015 to 2025. 2024 was the busiest year, with 12. The most frequent topics are Hepatitis C, Substance Abuse, Intravenous and Hepacivirus. Dr. Akiyama has published most often in Open Forum Infect Dis. Dr. Akiyama's most frequent co-authors are Anne C. Spaulding, MD, MPH, Ross F. MacDonald, MD and Jonathan Ross, MD.
Dr. Akiyama's papers by year, 2016 to 2025
Topics Dr. Akiyama writes about most
- Hepatitis C
- Substance Abuse, Intravenous
- Hepacivirus
- Antiviral Agents
- Hepatitis C, Chronic
- HIV Infections
- Drug Users
- Prisons
Dr. Akiyama's most frequent co-authors
- Anne C. Spaulding, MD, MPH17 shared papers
- Ross F. MacDonald, MD8 shared papers
- Jonathan Ross, MD5 shared papers
Recent publications by Dr. Akiyama
See who Dr. Akiyama researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Akiyama works with, so you can find a warm path to the right infectious disease specialists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Matthew Jiro Akiyama has worked on 1 clinical trial
Dmand AI links Dr. Akiyama to 1 clinical trial. Conditions studied include COVID-19 and Pneumonia, Viral.
Conditions in Dr. Akiyama's trials
- COVID-19
- Pneumonia, Viral
Recent clinical trials with Dr. Akiyama
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Matthew Jiro Akiyama received $16,934 in industry payments from 2016 to 2025
CMS Open Payments shows 27 general payments to Dr. Akiyama from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 83% of the total. Gilead Sciences, Inc. paid the most, $16,436.
General payments to Dr. Akiyama by program year, 2016 to 2025
General payments to Dr. Akiyama by kind, 2016 to 2025
- Consulting fees$13,99083%
- Travel and lodging$1,4509%
- Food and beverage$1,1497%
- Honoraria$3002%
- Speaker and faculty fees$450%
Companies that paid Dr. Akiyama the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Matthew Jiro Akiyama's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Matthew Jiro Akiyama
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Matthew Jiro Akiyama's NPI number?
Dr. Matthew Jiro Akiyama's NPI number is 1316259419. It was assigned on July 6, 2010, and it is active in the NPI Registry.
What kind of doctor is Dr. Matthew Jiro Akiyama?
Dr. Matthew Jiro Akiyama is an infectious disease specialist in Bronx, New York. The primary specialty in the NPI Registry is Infectious Disease Physician (taxonomy code 207RI0200X).
Where does Dr. Matthew Jiro Akiyama practice?
Dr. Akiyama practices at 1621 Eastchester Rd, Bronx, NY 10461. Dr. Akiyama's primary practice is Montefiore Medical Center in Bronx, New York.
What is Dr. Matthew Jiro Akiyama's office phone number?
The practice phone on file for Dr. Akiyama is (914) 377-4722.
What is Dr. Matthew Jiro Akiyama's medical license number?
Dr. Akiyama holds New York license 279474.
Which hospitals is Dr. Matthew Jiro Akiyama affiliated with?
Dr. Akiyama is affiliated with Montefiore Einstein Hospital-Moses Campus.
What medical group is Dr. Matthew Jiro Akiyama part of?
Dr. Akiyama is linked to Montefiore Einstein Faculty Practice Group.
Does Dr. Matthew Jiro Akiyama accept Medicare?
Yes. CMS data shows Dr. Akiyama billed Medicare for 114 services in 2022.
What is Dr. Matthew Jiro Akiyama's MIPS score?
Dr. Akiyama's MIPS final score for performance year 2024 is 100 out of 100, reported as part of a group.
What services does Dr. Matthew Jiro Akiyama bill to Medicare?
In 2022, Dr. Akiyama's most billed Medicare services were office visit, established patient (99215), hospital inpatient care (99233) and hospital inpatient care (99232).
Show 5 more questionsShow fewer questions
What drugs does Dr. Matthew Jiro Akiyama prescribe most?
In 2024 Medicare Part D data, Dr. Akiyama's most prescribed drugs by claims were Biktarvy, Atorvastatin Calcium and Triumeq.
Has Dr. Matthew Jiro Akiyama received payments from drug or device companies?
CMS Open Payments shows $16,934 in general payments to Dr. Akiyama from 6 companies from 2016 to 2025. The largest total came from Gilead Sciences, Inc.
How long has Dr. Matthew Jiro Akiyama been practicing?
Dr. Akiyama graduated from medical school in 2005, 21 years ago.
Does Dr. Matthew Jiro Akiyama do research?
Dmand AI links 98 publications to Dr. Akiyama, published from 2015 to 2025. Dr. Akiyama has worked on 1 clinical trial.
Who does Dr. Matthew Jiro Akiyama publish with?
Dr. Akiyama's most frequent co-authors are Anne C. Spaulding, MD, MPH (17 shared papers), Ross F. MacDonald, MD (8 shared papers) and Jonathan Ross, MD (5 shared papers).
Selling to infectious disease practices?
See infectious disease specialists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card